Literature DB >> 8415668

Replication-incompetent herpesvirus vector delivery of an interferon alpha gene inhibits human immunodeficiency virus replication in human monocytes.

J P Weir1, K L Elkins.   

Abstract

Human monocytes and macrophages are nondividing cells that serve as a major reservoir for human immunodeficiency virus (HIV) at all stages of infection. To investigate viral-mediated gene delivery as a means of inhibiting HIV replication in human monocytes, a replication-incompetent herpes simplex virus vector was developed that expressed human interferon alpha. Monocytes infected with this herpes simplex virus vector and then challenged with HIV showed dramatically reduced cytopathic effects and HIV replication compared to control treated monocytes. Similar effects on HIV replication were observed if monocytes were first infected with HIV and then treated with the recombinant vectors. These results demonstrate that replication-incompetent herpes simplex virus gene delivery of interferon alpha directly to human monocytes can greatly decrease HIV replication and suggest that such a vector might deliver therapeutically important genes directly to sites of HIV infection.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8415668      PMCID: PMC47517          DOI: 10.1073/pnas.90.19.9140

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  24 in total

1.  Activation of human immunodeficiency virus by herpesvirus infection: identification of a region within the long terminal repeat that responds to a trans-acting factor encoded by herpes simplex virus 1.

Authors:  J D Mosca; D P Bednarik; N B Raj; C A Rosen; J G Sodroski; W A Haseltine; G S Hayward; P M Pitha
Journal:  Proc Natl Acad Sci U S A       Date:  1987-11       Impact factor: 11.205

Review 2.  Genetic control of macrophage responses.

Authors:  R van Furth; W Sluiter; J T van Dissel
Journal:  Ann N Y Acad Sci       Date:  1986       Impact factor: 5.691

3.  Monocyte kinetic studies in normal and disease states.

Authors:  G Meuret; G Hoffmann
Journal:  Br J Haematol       Date:  1973-03       Impact factor: 6.998

Review 4.  Functional aspects of mononuclear phagocyte involvement in lung inflammation.

Authors:  D W Riches; P M Henson
Journal:  Ann N Y Acad Sci       Date:  1986       Impact factor: 5.691

5.  Construction and identification of bacterial plasmids containing nucleotide sequence for human leukocyte interferon.

Authors:  S Maeda; R McCandliss; M Gross; A Sloma; P C Familletti; J M Tabor; M Evinger; W P Levy; S Pestka
Journal:  Proc Natl Acad Sci U S A       Date:  1980-12       Impact factor: 11.205

6.  Activities of herpes simplex virus type 1 (HSV-1) ICP4 genes specifying nonsense peptides.

Authors:  N A DeLuca; P A Schaffer
Journal:  Nucleic Acids Res       Date:  1987-06-11       Impact factor: 16.971

7.  The use of beta-galactosidase as a marker gene to define the regulatory sequences of the herpes simplex virus type 1 glycoprotein C gene in recombinant herpesviruses.

Authors:  J P Weir; P R Narayanan
Journal:  Nucleic Acids Res       Date:  1988-11-11       Impact factor: 16.971

8.  Immunization with a vaccinia virus recombinant expressing herpes simplex virus type 1 glycoprotein D: long-term protection and effect of revaccination.

Authors:  J F Rooney; C Wohlenberg; K J Cremer; B Moss; A L Notkins
Journal:  J Virol       Date:  1988-05       Impact factor: 5.103

9.  Interferons and bacterial lipopolysaccharide protect macrophages from productive infection by human immunodeficiency virus in vitro.

Authors:  R S Kornbluth; P S Oh; J R Munis; P H Cleveland; D D Richman
Journal:  J Exp Med       Date:  1989-03-01       Impact factor: 14.307

10.  Efficient isolation and propagation of human immunodeficiency virus on recombinant colony-stimulating factor 1-treated monocytes.

Authors:  H E Gendelman; J M Orenstein; M A Martin; C Ferrua; R Mitra; T Phipps; L A Wahl; H C Lane; A S Fauci; D S Burke
Journal:  J Exp Med       Date:  1988-04-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.